Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for radiotherapy-induced diarrhea
NCT06783153Phase 2Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in radiation enteritis, sponsored by Mansoura University. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
rifaximin
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT06783153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06783153.